Why would a person with high levels of melatonin be asymptomatic during SARS-CoV-2 infection? A groundbreaking study on melatonin and SARS-CoV-2 published by Fernandes et al. on Jan 4 at Melatonin-Research shed light on why melatonin directly targets SARS-CoV-2...
By Doris Loh There is currently no gold standard treatment for SARS-CoV-2 infections. Several vaccines have completed Phase III trials with impressive success rates. Whether these vaccines will be as effective in the face of new strains with new mutation sites is a...
By Doris Loh This article is a condensed version containing important slides from the video presentation “Ancient Molecules for Healthy Hearts”. Slides may be copied and reproduced, provided proper credit is given. The entire video can be viewed by following this...
By Doris Loh The end of summer is approaching. Parents, schools and policy-makers are faced with the almost impossible task of weighing the benefits against risks of in-person education when virtual alternatives are available. What are the real risks facing...
By Doris Loh The following slide presentation was used for the interview by Jay Campbell on July 1, 2020. Contents may be shared and reprinted providing proper credit for the original podcast and this article is given. The July 1 video can be accessed via this...
By Doris Loh SARS-CoV-2 has now infected over 8.7 million people worldwide [1]. Although infection rates have slowed in some countries that were hit the hardest, such as China, United States, United Kingdom, Italy, Spain and France, other countries are reporting...